Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Insulet (PODD – Research Report) today and set a price target of ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

NDAQ:AHCO) AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity and Reduced Cost of Debt ...

Former President Donald Trump and Vice President Kamala Harris both want to lower prices, but whether their proposals would ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The company anticipates further patent issuances in the future, reinforcing its commitment to innovation and market leadership in insulin delivery technology. The MODD1 pump is designed to cater ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...

The global insulin pumps market, valued at USD 5.5 billion in 2022 ... This unique insulin administration system, which is ...

Embecta said its patch pump was designed with feedback from people with Type 2 diabetes. The company presented data in June finding ... assuming a mean daily insulin dose of 96 units. Embecta ...

The company anticipates further patent issuances in the future, reinforcing its commitment to innovation and market leadership in insulin delivery technology. The MODD1 pump is designed to cater to ...

Clinical Trials Arena has listed the leading clinical trial logistics companies and clinical trial supplies providers, based on its intel, insights, and decades-long experience in the sector.